€20.00
4.46% day before yesterday
L&S, Jun 28, 10:54 pm CET
ISIN
US09062W2044
Symbol
BLFS

BioLife Solutions, Inc. Target price 2024 - Analyst rating & recommendation

BioLife Solutions, Inc. Classifications & Recommendation:

Buy
100%

BioLife Solutions, Inc. Target price

Target price $24.78
Course $21.43
Price potential
Number of estimates 9
9 Analysts have issued a price target BioLife Solutions, Inc. 2025 . The average BioLife Solutions, Inc. target price is $24.78. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 9 Analysts recommend BioLife Solutions, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the BioLife Solutions, Inc. share has an average upside potential 2025 of . Most analysts recommend the BioLife Solutions, Inc. share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 143.27 107.92
11.43% 24.67%
EBITDA margin -31.58% 10.65%
155.90% 133.73%
Net margin -48.47% -23.13%
47.84% 52.28%

9 Analysts have issued a sales forecast BioLife Solutions, Inc. 2024 . The average BioLife Solutions, Inc. sales estimate is

$108m
unlock
. This is
21.40% lower
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$120m 12.53%
unlock
, the lowest is
$100m 27.17%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $143m 11.43%
2024
$108m 24.67%
unlock
2025
$122m 12.58%
unlock
2026
$150m 23.49%
unlock
2027
$227m 51.33%
unlock
2028
$289m 27.23%
unlock

5 Analysts have issued an BioLife Solutions, Inc. EBITDA forecast 2024. The average BioLife Solutions, Inc. EBITDA estimate is

$11.5m
unlock
. This is
126.68% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$12.4m 128.79%
unlock
, the lowest is
$10.5m 124.30%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $-45.2m 126.65%
2024
$11.5m 125.40%
unlock
2025
$21.4m 86.30%
unlock
2026
$32.6m 52.25%
unlock

EBITDA margin

2023 -31.58% 155.90%
2024
10.65% 133.73%
unlock
2025
17.62% 65.45%
unlock
2026
21.73% 23.33%
unlock

8 BioLife Solutions, Inc. Analysts have issued a net profit forecast 2024. The average BioLife Solutions, Inc. net profit estimate is

$-25.0m
unlock
. This is
61.80% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-20.1m 69.24%
unlock
, the lowest is
$-33.8m 48.25%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-69.4m 53.80%
2024
$-25.0m 64.06%
unlock
2025
$-14.8m 40.91%
unlock
2026
$5.7m 138.71%
unlock
2027
$51.2m 796.15%
unlock
2028
$90.9m 77.68%
unlock

Net margin

2023 -48.47% 47.84%
2024
-23.13% 52.28%
unlock
2025
-12.14% 47.51%
unlock
2026
3.81% 131.38%
unlock
2027
22.54% 491.60%
unlock
2028
31.47% 39.62%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -1.52 -0.55
53.80% 63.82%
P/E ratio negative
EV/Sales 9.11

8 Analysts have issued a BioLife Solutions, Inc. forecast for earnings per share. The average BioLife Solutions, Inc. <a href=/blog/eps>EPS is

$-0.55
unlock
. This is
61.54% higher
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-0.44 69.23%
unlock
, the lowest is
$-0.74 48.25%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-1.52 53.80%
2024
$-0.55 63.82%
unlock
2025
$-0.32 41.82%
unlock
2026
$0.13 140.63%
unlock
2027
$1.12 761.54%
unlock
2028
$1.99 77.68%
unlock

P/E ratio

Current -15.02 166.31%
2024
-39.23 161.19%
unlock
2025
-66.37 69.18%
unlock
2026
171.44 358.31%
unlock
2027
19.13 88.84%
unlock
2028
10.77 43.70%
unlock

Based on analysts' sales estimates for 2024, the BioLife Solutions, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 7.16 18.15%
2024
9.11 27.20%
unlock
2025
8.09 11.18%
unlock
2026
6.55 19.02%
unlock
2027
4.33 33.92%
unlock
2028
3.40 21.40%
unlock

P/S ratio

Current 7.19 17.25%
2024
9.15 27.22%
unlock
2025
8.13 11.18%
unlock
2026
6.58 19.02%
unlock
2027
4.35 33.92%
unlock
2028
3.42 21.40%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now